CABA · Cabaletta Bio, Inc.

Substantial doubt about the company's ability to continue as a going concern.

“We have identified conditions that raise substantial doubt about our ability to continue as a going concern. If we are unable to secure additional funding beyond our current cash position that enables our operations into mid-2027, we may be forced to delay, reduce or discontinue our product development programs efforts or other operations. Accordingly, the Company has concluded that substantial doubt exists about the Company's ability to continue as a going concern.”